English
简体中文
Total: £ 56.28
Published Date: 2025-06-23 | Pages: 134 | Tables: 142 | Pharma & Healthcare
In 2024, the global market size of Botanical Drug was estimated to be worth US$ 39810 million and is forecast to reach approximately US$ 54940 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans.
A botanical drug product consists of vegetable materials, which may include plant materials, algae, macroscopic fungi, or combinations thereof.
A botanical drug product may be available as (but not limited to) a solution, powder, tablet, capsule, elixir, topical, or injection.
Botanical drug products often have unique features, for example, complex mixtures, lack of a distinct active ingredient, and substantial prior human use. Fermentation products and highly purified or chemically modified botanical substances are not considered botanical drug products.
Global 5 largest manufacturers of Botanical Drug are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe and Tong Ren Tang, which make up about 30%.
China is the largest market, with a share over 60%. In terms of product type, OTC occupy the largest share of the total market, over 60%. And in terms of application, the largest application is Cardiovascular, followed by Respiratory System and Tumor.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Botanical Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botanical Drug.
The Botanical Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Botanical Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Botanical Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Segment by Type
Prescription Drug
OTC
Segment by Application
Cardiovascular
Tumor
Respiratory System
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Botanical Drug in global and regional level.
Chapter 3: Detailed analysis of Botanical Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical Drug revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Botanical Drug Product Introduction
1.2 Market by Type
1.2.1 Global Botanical Drug Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Botanical Drug Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Botanical Drug Market Size Estimates and Forecasts
2.2 Botanical Drug Market Size by Region: 2024 Versus 2031
2.2.1 Global Botanical Drug Revenue by Region: 2020-2025
2.2.2 Global Botanical Drug Revenue Forecast by Region (2026-2031)
2.2.3 Global Botanical Drug Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Botanical Drug Revenue by Type (2020-2031)
3.1.2 Global Botanical Drug Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Botanical Drug Revenue by Application (2020-2031)
3.2.2 Global Botanical Drug Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Prescription Drug of Botanical Drug Revenue Market Share by Application
3.3.2 OTC of Botanical Drug Revenue Market Share by Application
4 Global Botanical Drug by Company
4.1 Global Botanical Drug Revenue by Company (2020-2025)
4.2 Global Botanical Drug Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Botanical Drug Companies around the World: Ranking by Revenue
4.3.2 Global Botanical Drug Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Botanical Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Botanical Drug Companies Headquarters & Product Type
4.4.1 Global Botanical Drug Companies Headquarters
4.4.2 Date of International Companies Enter into Botanical Drug Market
4.4.3 Global Botanical Drug Companies Product & Service
4.4.4 Prescription Drug Revenue Market Share of Botanical Drug by Company
4.4.5 OTC Revenue Market Share of Botanical Drug by Company
4.5 Global Botanical Drug Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Buchang Pharmaceuticals
5.1.1 Buchang Pharmaceuticals Corporation Information
5.1.2 Buchang Pharmaceuticals Description, Business Overview
5.1.3 Buchang Pharmaceuticals Botanical Drug Products Offered
5.1.4 Buchang Pharmaceuticals Botanical Drug Revenue and Gross Margin (2020-2025)
5.1.5 Buchang Pharmaceuticals Botanical Drug Revenue by Product in 2024
5.1.6 Buchang Pharmaceuticals Botanical Drug Revenue by Application in 2024
5.1.7 Buchang Pharmaceuticals Botanical Drug Revenue by Geographic Area in 2024
5.1.8 Buchang Pharmaceuticals Recent Developments
5.2 China TCM
5.2.1 China TCM Corporation Information
5.2.2 China TCM Description, Business Overview
5.2.3 China TCM Botanical Drug Products Offered
5.2.4 China TCM Botanical Drug Revenue and Gross Margin (2020-2025)
5.2.5 China TCM Botanical Drug Revenue by Product in 2024
5.2.6 China TCM Botanical Drug Revenue by Application in 2024
5.2.7 China TCM Botanical Drug Revenue by Geographic Area in 2024
5.2.8 China TCM Recent Developments
5.3 Tsumura
5.3.1 Tsumura Corporation Information
5.3.2 Tsumura Description, Business Overview
5.3.3 Tsumura Botanical Drug Products Offered
5.3.4 Tsumura Botanical Drug Revenue and Gross Margin (2020-2025)
5.3.5 Tsumura Botanical Drug Revenue by Product in 2024
5.3.6 Tsumura Botanical Drug Revenue by Application in 2024
5.3.7 Tsumura Botanical Drug Revenue by Geographic Area in 2024
5.3.8 Tsumura Recent Developments
5.4 Schwabe
5.4.1 Schwabe Corporation Information
5.4.2 Schwabe Description, Business Overview
5.4.3 Schwabe Botanical Drug Products Offered
5.4.4 Schwabe Botanical Drug Revenue and Gross Margin (2020-2025)
5.4.5 Schwabe Botanical Drug Revenue by Product in 2024
5.4.6 Schwabe Botanical Drug Revenue by Application in 2024
5.4.7 Schwabe Botanical Drug Revenue by Geographic Area in 2024
5.4.8 Schwabe Recent Developments
5.5 Tong Ren Tang
5.5.1 Tong Ren Tang Corporation Information
5.5.2 Tong Ren Tang Description, Business Overview
5.5.3 Tong Ren Tang Botanical Drug Products Offered
5.5.4 Tong Ren Tang Botanical Drug Revenue and Gross Margin (2020-2025)
5.5.5 Tong Ren Tang Botanical Drug Revenue by Product in 2024
5.5.6 Tong Ren Tang Botanical Drug Revenue by Application in 2024
5.5.7 Tong Ren Tang Botanical Drug Revenue by Geographic Area in 2024
5.5.8 Tong Ren Tang Recent Developments
5.6 Jumpcan Pharmaceutical
5.6.1 Jumpcan Pharmaceutical Corporation Information
5.6.2 Jumpcan Pharmaceutical Description, Business Overview
5.6.3 Jumpcan Pharmaceutical Botanical Drug Products Offered
5.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue and Gross Margin (2020-2025)
5.6.5 Jumpcan Pharmaceutical Botanical Drug Revenue by Product in 2024
5.6.6 Jumpcan Pharmaceutical Botanical Drug Revenue by Application in 2024
5.6.7 Jumpcan Pharmaceutical Botanical Drug Revenue by Geographic Area in 2024
5.6.8 Jumpcan Pharmaceutical Recent Developments
5.7 Guangzhou Baiyunshan Pharmaceutical
5.7.1 Guangzhou Baiyunshan Pharmaceutical Corporation Information
5.7.2 Guangzhou Baiyunshan Pharmaceutical Description, Business Overview
5.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Products Offered
5.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue and Gross Margin (2020-2025)
5.7.5 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue by Product in 2024
5.7.6 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue by Application in 2024
5.7.7 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue by Geographic Area in 2024
5.7.8 Guangzhou Baiyunshan Pharmaceutical Recent Developments
5.8 Yunnan Baiyao
5.8.1 Yunnan Baiyao Corporation Information
5.8.2 Yunnan Baiyao Description, Business Overview
5.8.3 Yunnan Baiyao Botanical Drug Products Offered
5.8.4 Yunnan Baiyao Botanical Drug Revenue and Gross Margin (2020-2025)
5.8.5 Yunnan Baiyao Botanical Drug Revenue by Product in 2024
5.8.6 Yunnan Baiyao Botanical Drug Revenue by Application in 2024
5.8.7 Yunnan Baiyao Botanical Drug Revenue by Geographic Area in 2024
5.8.8 Yunnan Baiyao Recent Developments
5.9 Tasly Holding Group
5.9.1 Tasly Holding Group Corporation Information
5.9.2 Tasly Holding Group Description, Business Overview
5.9.3 Tasly Holding Group Botanical Drug Products Offered
5.9.4 Tasly Holding Group Botanical Drug Revenue and Gross Margin (2020-2025)
5.9.5 Tasly Holding Group Botanical Drug Revenue by Product in 2024
5.9.6 Tasly Holding Group Botanical Drug Revenue by Application in 2024
5.9.7 Tasly Holding Group Botanical Drug Revenue by Geographic Area in 2024
5.9.8 Tasly Holding Group Recent Developments
5.10 Bionorica Se
5.10.1 Bionorica Se Corporation Information
5.10.2 Bionorica Se Description, Business Overview
5.10.3 Bionorica Se Botanical Drug Products Offered
5.10.4 Bionorica Se Botanical Drug Revenue and Gross Margin (2020-2025)
5.10.5 Bionorica Se Botanical Drug Revenue by Product in 2024
5.10.6 Bionorica Se Botanical Drug Revenue by Application in 2024
5.10.7 Bionorica Se Botanical Drug Revenue by Geographic Area in 2024
5.10.8 Bionorica Se Recent Developments
5.11 Huarun 999
5.11.1 Huarun 999 Corporation Information
5.11.2 Huarun 999 Description, Business Overview
5.11.3 Huarun 999 Botanical Drug Products Offered
5.11.4 Huarun 999 Botanical Drug Revenue and Gross Margin (2020-2025)
5.11.5 Huarun 999 Botanical Drug Revenue by Product in 2024
5.11.6 Huarun 999 Botanical Drug Revenue by Application in 2024
5.11.7 Huarun 999 Botanical Drug Revenue by Geographic Area in 2024
5.11.8 Huarun 999 Recent Developments
5.12 Taiji
5.12.1 Taiji Corporation Information
5.12.2 Taiji Description, Business Overview
5.12.3 Taiji Botanical Drug Products Offered
5.12.4 Taiji Botanical Drug Revenue and Gross Margin (2020-2025)
5.12.5 Taiji Botanical Drug Revenue by Product in 2024
5.12.6 Taiji Botanical Drug Revenue by Application in 2024
5.12.7 Taiji Botanical Drug Revenue by Geographic Area in 2024
5.12.8 Taiji Recent Developments
5.13 Weleda
5.13.1 Weleda Corporation Information
5.13.2 Weleda Description, Business Overview
5.13.3 Weleda Botanical Drug Products Offered
5.13.4 Weleda Botanical Drug Revenue and Gross Margin (2020-2025)
5.13.5 Weleda Botanical Drug Revenue by Product in 2024
5.13.6 Weleda Botanical Drug Revenue by Application in 2024
5.13.7 Weleda Botanical Drug Revenue by Geographic Area in 2024
5.13.8 Weleda Recent Developments
5.14 Kwangdong
5.14.1 Kwangdong Corporation Information
5.14.2 Kwangdong Description, Business Overview
5.14.3 Kwangdong Botanical Drug Products Offered
5.14.4 Kwangdong Botanical Drug Revenue and Gross Margin (2020-2025)
5.14.5 Kwangdong Botanical Drug Revenue by Product in 2024
5.14.6 Kwangdong Botanical Drug Revenue by Application in 2024
5.14.7 Kwangdong Botanical Drug Revenue by Geographic Area in 2024
5.14.8 Kwangdong Recent Developments
5.15 GW Pharmaceuticals
5.15.1 GW Pharmaceuticals Corporation Information
5.15.2 GW Pharmaceuticals Description, Business Overview
5.15.3 GW Pharmaceuticals Botanical Drug Products Offered
5.15.4 GW Pharmaceuticals Botanical Drug Revenue and Gross Margin (2020-2025)
5.15.5 GW Pharmaceuticals Botanical Drug Revenue by Product in 2024
5.15.6 GW Pharmaceuticals Botanical Drug Revenue by Application in 2024
5.15.7 GW Pharmaceuticals Botanical Drug Revenue by Geographic Area in 2024
5.15.8 GW Pharmaceuticals Recent Developments
6 North America
6.1 North America Botanical Drug Market Size YoY Growth 2020-2031
6.2 North America Botanical Drug Market Facts & Figures by Country (2020-2031)
6.3 North America Botanical Drug Revenue by Type (2020-2025)
6.4 North America Botanical Drug Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Botanical Drug Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Botanical Drug Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Botanical Drug Revenue by Type (2020-2025)
7.4 Asia-Pacific Botanical Drug Revenue by Application (2020-2025)
8 Europe
8.1 Europe Botanical Drug Market Size YoY Growth 2020-2031
8.2 Europe Botanical Drug Market Facts & Figures by Country (2020-2031)
8.3 Europe Botanical Drug Revenue by Type (2020-2025)
8.4 Europe Botanical Drug Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Botanical Drug Market Size YoY Growth 2020-2031
9.2 Latin America Botanical Drug Market Facts & Figures by Country (2020-2031)
9.3 Latin America Botanical Drug Revenue by Type (2020-2025)
9.4 Latin America Botanical Drug Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Botanical Drug Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Botanical Drug Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Botanical Drug Revenue by Type (2020-2025)
10.4 Middle East and Africa Botanical Drug Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Botanical Drug Supply Chain Analysis
11.2 Botanical Drug Key Raw Materials and Upstream Suppliers
11.3 Botanical Drug Clients Analysis
11.4 Botanical Drug Sales Channel and Sales Model Analysis
11.4.1 Botanical Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Botanical Drug Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Botanical Drug Distributors
12 Botanical Drug Market Dynamics
12.1 Botanical Drug Industry Trends
12.2 Botanical Drug Market Drivers
12.3 Botanical Drug Market Challenges
12.4 Botanical Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Botanical Drug Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Botanical Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Botanical Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Botanical Drug Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Botanical Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Botanical Drug Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Botanical Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Botanical Drug Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Botanical Drug Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Botanical Drug Revenue by Company (2020-2025) & (US$ Million)
Table 11. Botanical Drug Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Botanical Drug Players by Revenue (US$ Million) in 2024
Table 13. Global Botanical Drug Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Botanical Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botanical Drug as of 2024)
Table 15. Global Botanical Drug Companies Headquarters
Table 16. Date of International Companies Enter into Botanical Drug Market
Table 17. Global Botanical Drug Companies Product & Service
Table 18. Global Botanical Drug Mergers & Acquisitions, Expansion Plans
Table 19. Buchang Pharmaceuticals Corporation Information
Table 20. Buchang Pharmaceuticals Description and Business Overview
Table 21. Buchang Pharmaceuticals Botanical Drug Product
Table 22. Buchang Pharmaceuticals Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Buchang Pharmaceuticals Revenue Proportion of Botanical Drug by Product in 2024
Table 24. Buchang Pharmaceuticals Revenue Proportion of Botanical Drug by Application in 2024
Table 25. Buchang Pharmaceuticals Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 26. Buchang Pharmaceuticals Recent Developments
Table 27. China TCM Corporation Information
Table 28. China TCM Description and Business Overview
Table 29. China TCM Botanical Drug Product
Table 30. China TCM Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. China TCM Revenue Proportion of Botanical Drug by Product in 2024
Table 32. China TCM Revenue Proportion of Botanical Drug by Application in 2024
Table 33. China TCM Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 34. China TCM Recent Developments
Table 35. Tsumura Corporation Information
Table 36. Tsumura Description and Business Overview
Table 37. Tsumura Botanical Drug Product
Table 38. Tsumura Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Tsumura Revenue Proportion of Botanical Drug by Product in 2024
Table 40. Tsumura Revenue Proportion of Botanical Drug by Application in 2024
Table 41. Tsumura Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 42. Tsumura Recent Developments
Table 43. Schwabe Corporation Information
Table 44. Schwabe Description and Business Overview
Table 45. Schwabe Botanical Drug Product
Table 46. Schwabe Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Schwabe Revenue Proportion of Botanical Drug by Product in 2024
Table 48. Schwabe Revenue Proportion of Botanical Drug by Application in 2024
Table 49. Schwabe Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 50. Schwabe Recent Developments
Table 51. Tong Ren Tang Corporation Information
Table 52. Tong Ren Tang Description and Business Overview
Table 53. Tong Ren Tang Botanical Drug Product
Table 54. Tong Ren Tang Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Tong Ren Tang Revenue Proportion of Botanical Drug by Product in 2024
Table 56. Tong Ren Tang Revenue Proportion of Botanical Drug by Application in 2024
Table 57. Tong Ren Tang Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 58. Tong Ren Tang Recent Developments
Table 59. Jumpcan Pharmaceutical Corporation Information
Table 60. Jumpcan Pharmaceutical Description and Business Overview
Table 61. Jumpcan Pharmaceutical Botanical Drug Product
Table 62. Jumpcan Pharmaceutical Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Jumpcan Pharmaceutical Revenue Proportion of Botanical Drug by Product in 2024
Table 64. Jumpcan Pharmaceutical Revenue Proportion of Botanical Drug by Application in 2024
Table 65. Jumpcan Pharmaceutical Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 66. Jumpcan Pharmaceutical Recent Developments
Table 67. Guangzhou Baiyunshan Pharmaceutical Corporation Information
Table 68. Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
Table 69. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product
Table 70. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Guangzhou Baiyunshan Pharmaceutical Revenue Proportion of Botanical Drug by Product in 2024
Table 72. Guangzhou Baiyunshan Pharmaceutical Revenue Proportion of Botanical Drug by Application in 2024
Table 73. Guangzhou Baiyunshan Pharmaceutical Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 74. Guangzhou Baiyunshan Pharmaceutical Recent Developments
Table 75. Yunnan Baiyao Corporation Information
Table 76. Yunnan Baiyao Description and Business Overview
Table 77. Yunnan Baiyao Botanical Drug Product
Table 78. Yunnan Baiyao Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Yunnan Baiyao Revenue Proportion of Botanical Drug by Product in 2024
Table 80. Yunnan Baiyao Revenue Proportion of Botanical Drug by Application in 2024
Table 81. Yunnan Baiyao Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 82. Yunnan Baiyao Recent Developments
Table 83. Tasly Holding Group Corporation Information
Table 84. Tasly Holding Group Description and Business Overview
Table 85. Tasly Holding Group Botanical Drug Product
Table 86. Tasly Holding Group Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Tasly Holding Group Revenue Proportion of Botanical Drug by Product in 2024
Table 88. Tasly Holding Group Revenue Proportion of Botanical Drug by Application in 2024
Table 89. Tasly Holding Group Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 90. Tasly Holding Group Recent Developments
Table 91. Bionorica Se Corporation Information
Table 92. Bionorica Se Description and Business Overview
Table 93. Bionorica Se Botanical Drug Product
Table 94. Bionorica Se Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Bionorica Se Revenue Proportion of Botanical Drug by Product in 2024
Table 96. Bionorica Se Revenue Proportion of Botanical Drug by Application in 2024
Table 97. Bionorica Se Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 98. Bionorica Se Recent Developments
Table 99. Huarun 999 Corporation Information
Table 100. Huarun 999 Description and Business Overview
Table 101. Huarun 999 Botanical Drug Product
Table 102. Huarun 999 Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Huarun 999 Revenue Proportion of Botanical Drug by Product in 2024
Table 104. Huarun 999 Revenue Proportion of Botanical Drug by Application in 2024
Table 105. Huarun 999 Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 106. Huarun 999 Recent Developments
Table 107. Taiji Corporation Information
Table 108. Taiji Description and Business Overview
Table 109. Taiji Botanical Drug Product
Table 110. Taiji Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Taiji Revenue Proportion of Botanical Drug by Product in 2024
Table 112. Taiji Revenue Proportion of Botanical Drug by Application in 2024
Table 113. Taiji Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 114. Taiji Recent Developments
Table 115. Weleda Corporation Information
Table 116. Weleda Description and Business Overview
Table 117. Weleda Botanical Drug Product
Table 118. Weleda Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Weleda Revenue Proportion of Botanical Drug by Product in 2024
Table 120. Weleda Revenue Proportion of Botanical Drug by Application in 2024
Table 121. Weleda Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 122. Weleda Recent Developments
Table 123. Kwangdong Corporation Information
Table 124. Kwangdong Description and Business Overview
Table 125. Kwangdong Botanical Drug Product
Table 126. Kwangdong Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Kwangdong Revenue Proportion of Botanical Drug by Product in 2024
Table 128. Kwangdong Revenue Proportion of Botanical Drug by Application in 2024
Table 129. Kwangdong Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 130. Kwangdong Recent Developments
Table 131. GW Pharmaceuticals Corporation Information
Table 132. GW Pharmaceuticals Description and Business Overview
Table 133. GW Pharmaceuticals Botanical Drug Product
Table 134. GW Pharmaceuticals Botanical Drug Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. GW Pharmaceuticals Revenue Proportion of Botanical Drug by Product in 2024
Table 136. GW Pharmaceuticals Revenue Proportion of Botanical Drug by Application in 2024
Table 137. GW Pharmaceuticals Revenue Proportion of Botanical Drug by Geographic Area in 2024
Table 138. GW Pharmaceuticals Recent Developments
Table 139. North America Botanical Drug Revenue by Country (2020-2025) & (US$ Million)
Table 140. North America Botanical Drug Revenue by Country (2026-2031) & (US$ Million)
Table 141. North America Botanical Drug Revenue by Type (2020-2025) & (US$ Million)
Table 142. North America Botanical Drug Revenue by Application (2020-2025) & (US$ Million)
Table 143. Asia-Pacific Botanical Drug Revenue by Region (2020-2025) & (US$ Million)
Table 144. Asia-Pacific Botanical Drug Revenue by Region (2026-2031) & (US$ Million)
Table 145. Asia-Pacific Botanical Drug Revenue by Type (2020-2025) & (US$ Million)
Table 146. Asia-Pacific Botanical Drug Revenue by Application (2020-2025) & (US$ Million)
Table 147. Europe Botanical Drug Revenue by Country (2020-2025) & (US$ Million)
Table 148. Europe Botanical Drug Revenue by Country (2026-2031) & (US$ Million)
Table 149. Europe Botanical Drug Revenue by Type (2020-2025) & (US$ Million)
Table 150. Europe Botanical Drug Revenue by Application (2020-2025) & (US$ Million)
Table 151. Latin America Botanical Drug Revenue by Country (2020-2025) & (US$ Million)
Table 152. Latin America Botanical Drug Revenue by Country (2026-2031) & (US$ Million)
Table 153. Latin America Botanical Drug Revenue by Type (2020-2025) & (US$ Million)
Table 154. Latin America Botanical Drug Revenue by Application (2020-2025) & (US$ Million)
Table 155. Middle East and Africa Botanical Drug Revenue by Country (2020-2025) & (US$ Million)
Table 156. Middle East and Africa Botanical Drug Revenue by Country (2026-2031) & (US$ Million)
Table 157. Middle East and Africa Botanical Drug Revenue by Type (2020-2025) & (US$ Million)
Table 158. Middle East and Africa Botanical Drug Revenue by Application (2020-2025) & (US$ Million)
Table 159. Botanical Drug Key Raw Materials, Industry Status and Trend
Table 160. Botanical Drug Key Raw Materials and Upstream Suppliers
Table 161. Botanical Drug Clients Status and Trend
Table 162. Botanical Drug Typical Clients
Table 163. Botanical Drug Distributors
Table 164. Botanical Drug Market Trends
Table 165. Botanical Drug Market Drivers
Table 166. Botanical Drug Market Challenges
Table 167. Botanical Drug Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Botanical Drug Product Picture
Figure 2. Global Botanical Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Botanical Drug Revenue Market Share by Type in 2024 & 2031
Figure 4. Prescription Drug Product Picture
Figure 5. OTC Product Picture
Figure 6. Global Botanical Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Botanical Drug Revenue Market Share by Application in 2024 & 2031
Figure 8. Cardiovascular
Figure 9. Tumor
Figure 10. Respiratory System
Figure 11. Other
Figure 12. Botanical Drug Report Years Considered
Figure 13. Global Botanical Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Botanical Drug Market Size (2020-2031) & (US$ Million)
Figure 15. Global Botanical Drug Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Botanical Drug Revenue Market Share by Region (2020-2031)
Figure 17. Global Botanical Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Botanical Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Prescription Drug of Botanical Drug Revenue Market Share by Application, 2024 VS 2031
Figure 20. OTC of Botanical Drug Revenue Market Share by Application, 2024 VS 2031
Figure 21. Botanical Drug Revenue Share by Company (2024)
Figure 22. Botanical Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Prescription Drug Revenue Proportion by Company in 2024
Figure 24. OTC Revenue Proportion by Company in 2024
Figure 25. North America Botanical Drug Revenue 2020-2031 (US$ Million)
Figure 26. North America Botanical Drug Revenue Market Share by Type (2020-2025)
Figure 27. North America Botanical Drug Revenue Market Share by Application (2020-2025)
Figure 28. Asia-Pacific Botanical Drug Revenue 2020-2031 (US$ Million)
Figure 29. Asia-Pacific Botanical Drug Revenue Market Share by Region (2020-2031)
Figure 30. Asia-Pacific Botanical Drug Revenue Market Share by Type (2020-2025)
Figure 31. Asia-Pacific Botanical Drug Revenue Market Share by Application (2020-2025)
Figure 32. Europe Botanical Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 33. Europe Botanical Drug Revenue Market Share by Country (2020-2031)
Figure 34. Europe Botanical Drug Revenue Market Share by Type (2020-2025)
Figure 35. Europe Botanical Drug Revenue Market Share by Application (2020-2025)
Figure 36. Latin America Botanical Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Latin America Botanical Drug Revenue Market Share by Country (2020-2031)
Figure 38. Latin America Botanical Drug Revenue Market Share by Type (2020-2025)
Figure 39. Latin America Botanical Drug Revenue Market Share by Application (2020-2025)
Figure 40. Middle East and Africa Botanical Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Middle East and Africa Botanical Drug Revenue Market Share by Country (2020-2031)
Figure 42. Middle East and Africa Botanical Drug Revenue Market Share by Type (2020-2025)
Figure 43. Middle East and Africa Botanical Drug Revenue Market Share by Application (2020-2025)
Figure 44. Botanical Drug Supply Chain (Upstream and Downstream Market)
Figure 45. Global Production Market Share of Botanical Drug Raw Materials by Region in 2024
Figure 46. Botanical Drug Distribution Channels
Figure 47. Global Botanical Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 48. Global Botanical Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
